Free Trial

Clover Health Investments (NASDAQ:CLOV) Shares Up 4% - Here's What Happened

Clover Health Investments logo with Medical background

Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report)'s share price was up 4% during mid-day trading on Monday . The stock traded as high as $4.24 and last traded at $4.16. Approximately 1,550,396 shares traded hands during mid-day trading, a decline of 81% from the average daily volume of 8,079,142 shares. The stock had previously closed at $4.00.

Wall Street Analyst Weigh In

Separately, UBS Group assumed coverage on shares of Clover Health Investments in a research report on Monday, October 7th. They set a "neutral" rating and a $4.00 target price on the stock.

Check Out Our Latest Stock Analysis on CLOV

Clover Health Investments Trading Up 1.5 %

The firm has a market capitalization of $2.02 billion, a price-to-earnings ratio of -11.91 and a beta of 2.13. The stock has a fifty day moving average price of $3.14 and a 200-day moving average price of $1.84.

Clover Health Investments (NASDAQ:CLOV - Get Free Report) last released its quarterly earnings data on Monday, August 5th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.05. Clover Health Investments had a negative return on equity of 36.55% and a negative net margin of 7.30%. The firm had revenue of $356.26 million during the quarter, compared to analyst estimates of $338.70 million. During the same period in the prior year, the company posted ($0.06) earnings per share. On average, equities analysts expect that Clover Health Investments, Corp. will post -0.13 EPS for the current year.

Hedge Funds Weigh In On Clover Health Investments

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CLOV. Viewpoint Capital Management LLC boosted its holdings in shares of Clover Health Investments by 96.8% in the 2nd quarter. Viewpoint Capital Management LLC now owns 30,500 shares of the company's stock worth $38,000 after acquiring an additional 15,000 shares in the last quarter. Jaffetilchin Investment Partners LLC raised its position in Clover Health Investments by 30.2% in the 1st quarter. Jaffetilchin Investment Partners LLC now owns 49,741 shares of the company's stock valued at $39,000 after purchasing an additional 11,550 shares during the last quarter. Vanguard Personalized Indexing Management LLC grew its holdings in shares of Clover Health Investments by 54.4% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 34,372 shares of the company's stock worth $42,000 after purchasing an additional 12,104 shares during the last quarter. Marshall Wace LLP acquired a new stake in shares of Clover Health Investments in the second quarter valued at $55,000. Finally, Bleakley Financial Group LLC raised its holdings in shares of Clover Health Investments by 98.9% in the third quarter. Bleakley Financial Group LLC now owns 20,090 shares of the company's stock valued at $57,000 after buying an additional 9,988 shares during the last quarter. 19.77% of the stock is currently owned by institutional investors and hedge funds.

About Clover Health Investments

(Get Free Report)

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.

Featured Stories

Should you invest $1,000 in Clover Health Investments right now?

Before you consider Clover Health Investments, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clover Health Investments wasn't on the list.

While Clover Health Investments currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines